We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

213 hedge funds and large institutions have $685M invested in Supernus Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 82 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $3.77M | Put options by funds: $1.57M

21% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 28

13% more capital invested

Capital invested by funds: $604M → $685M (+$80.6M)

2% more funds holding

Funds holding: 209 → 213 (+4)

1% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 82

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
213
Holders Change
+4
Holders Change %
+1.91%
% of All Funds
5.68%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
34
Increased
83
Reduced
82
Closed
28
Calls
$3.77M
Puts
$1.57M
Net Calls
+$2.2M
Net Calls Change
+$2.18M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$12.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$8.18M
4
RIM
Ranger Investment Management
Texas
+$5.55M
5
GIM
Granahan Investment Management
Massachusetts
+$5.09M

Top Sellers

1
KCM
Kornitzer Capital Management
Kansas
-$6.06M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.67M
3
Invesco
Invesco
Georgia
-$5.35M
4
MRM
Michael R. Murphy
-$4.95M
5
State Street
State Street
Massachusetts
-$4.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$8.39M +$602K +46,100 +9%
MRM
27
Michael R. Murphy
$8.26M -$4.95M -378,989 -41%
MOACM
28
Mutual of America Capital Management
New York
$8.2M -$21.3K -1,635 -0.3%
RHJA
29
Rice Hall James & Associates
California
$8.18M +$775K +59,377 +12%
Northern Trust
30
Northern Trust
Illinois
$7.82M +$1.5M +114,771 +28%
MCM
31
McKinley Capital Management
Alaska
$6.97M +$1.21M +92,541 +25%
BG
32
Bellevue Group
Switzerland
$6.72M +$5.75M +441,000 New
FPC
33
Falcon Point Capital
California
$6.23M +$1.36M +103,876 +34%
Bank of America
34
Bank of America
North Carolina
$6.02M +$23.9K +1,831 +0.5%
GIM
35
Granahan Investment Management
Massachusetts
$5.95M +$5.09M +389,840 New
OAM
36
Oxford Asset Management
United Kingdom
$5.21M -$644K -49,368 -13%
GIP
37
Granite Investment Partners
California
$5.18M +$3.56M +272,923 +410%
EAM
38
EverPoint Asset Management
Connecticut
$5.03M +$1.04M +80,000 +32%
Skandinaviska Enskilda Banken (SEB)
39
Skandinaviska Enskilda Banken (SEB)
Sweden
$4.64M -$1.36M -104,600 -26%
PAM
40
Panagora Asset Management
Massachusetts
$4.62M +$946K +72,517 +31%
SO
41
STRS Ohio
Ohio
$4.48M +$130K +10,000 +4%
IHM
42
Iguana Healthcare Management
New York
$4.19M +$1.63M +125,000 +83%
RPAM
43
Rhenman & Partners Asset Management
Sweden
$4.12M -$235K -18,000 -6%
PCM
44
Portolan Capital Management
Massachusetts
$3.98M +$1.02M +78,132 +43%
CCMH
45
Cornerstone Capital Management Holdings
New York
$3.85M +$1.68M +129,000 +104%
GCP
46
GSA Capital Partners
United Kingdom
$3.85M +$425K +32,537 +15%
AIS
47
AlphaOne Investment Services
Pennsylvania
$3.78M +$103K +7,874 +3%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$3.76M +$528K +40,458 +20%
CWG
49
C WorldWide Group
Denmark
$3.63M – – –
Principal Financial Group
50
Principal Financial Group
Iowa
$3.6M +$119K +9,127 +4%
1
2
3 4 5

SUPN Hedge Fund Activity: Q1 2016 in Review

213 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q1 2016, worth a combined $685M — up 13% from $604M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new SUPN positions and 28 closed out — a net gain of 6 holders — while 83 added to existing stakes and 82 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $12.3M. The largest seller was Kornitzer Capital Management, cutting an estimated $6.06M.

  • 213 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q1 2016, up from 209 in Q4 2015.
  • Funds reported $685M of Supernus Pharmaceuticals stock for Q1 2016, up 13% quarter-over-quarter.
  • 34 funds opened new Supernus Pharmaceuticals positions in Q1 2016 and 28 closed out, a net change of +6 holders.
  • The largest Supernus Pharmaceuticals buyer in Q1 2016 was Point72 Asset Management, an estimated $12.3M added.
  • The largest Supernus Pharmaceuticals seller in Q1 2016 was Kornitzer Capital Management, an estimated $6.06M sold.

Based on aggregated 13F filings for Q1 2016.